Cargando…
CAR T-Cell Therapy: Adverse Events and Management
Chimeric antigen receptor (CAR) T-cell therapy is an exciting innovation in the treatment of cancer. However, CAR T-cell therapies have been associated with unique adverse events (AEs), including cytokine release syndrome (CRS) and neurologic events (also known as CAR T-cell–related encephalopathy s...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Harborside Press LLC
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521123/ https://www.ncbi.nlm.nih.gov/pubmed/33520343 http://dx.doi.org/10.6004/jadpro.2019.10.4.11 |